Highlights d C. elegans mRNA decay factors affect axon regeneration and maintenance d The LSM14 ortholog CAR-1 is a repressor of axon regeneration d CAR-1 represses expression of the mitochondrial calcium regulator MICU-1 d Axon injury triggers mitochondrial calcium uptake regulated by MICU-1
How mRNA decay pathways regulate cellular function in vivo with specificity is poorly understood. Here, we show that C. elegans mRNA decay factors, including the translational repressors CAR-1/LSM14 and CGH-1/DDX6, and the decapping enzymes DCAP-1/ DCP1, function in neurons to differentially regulate axon development, maintenance, and regrowth following injury. In neuronal cell bodies, CAR-1 fully colocalizes with CGH-1 and partially colocalizes with DCAP-1, suggesting that mRNA decay components form at least two types of cytoplasmic granules. Following axon injury in adult neurons, loss of CAR-1 or CGH-1 results in increased axon regrowth and growth cone formation, whereas loss of DCAP-1 or DCAP-2 results in reduced regrowth. To determine how CAR-1 inhibits regrowth, we analyzed mRNAs bound to pan-neuronally expressed GFP::CAR-1 using a crosslinking and immunoprecipitation-based approach. Among the putative mRNA targets of CAR-1, we characterized the roles of micu-1, a regulator of the mitochondrial calcium uniporter MCU-1, in axon injury. We show that loss of car-1 results increased MICU-1 protein levels, and that enhanced axon regrowth in car-1 mutants is dependent on micu-1 and mcu-1. Moreover, axon injury induces transient calcium influx into axonal mitochondria, dependent on MCU-1. In car-1 loss-of-function mutants and in micu-1 overexpressing animals, the axonal mitochondrial calcium influx is more sustained, which likely underlies enhanced axon regrowth. Our data uncover a novel pathway that controls axon regrowth through axonal mitochondrial calcium uptake.
INTRODUCTION
Mature mRNAs are either actively translated or exist in a translational repressed state that can be targeted for degradation by mRNA decay factors. Extensive biochemical studies show that the recognition of mRNAs by the mRNA decay factor LSM14 and DEAD-box RNA helicase DDX6 leads to translational repression, followed by irreversible removal of the 5 0 cap by decapping enzymes DCP1 and DCP2, and mRNA degradation by the exonuclease XRN1 (reviewed in [1] ). In multiple cell types, depletion of mRNA decay factors usually leads to accumulation of stabilized mRNAs. However, increasing evidence suggests that mRNA decay factors exhibit a high degree of selectivity in mRNA stability regulation [2] . Therefore, it is crucial to identify the mRNA targets of mRNA decay factors to provide a better understanding of their cellular functions.
Neurons are polarized cells that are primed for a high degree of selective and dynamic regulation of gene expression. mRNA decay factors are widely expressed in neurons of C. elegans, Drosophila, and mammals [3] [4] [5] [6] . For example, Drosophila Me31B/DDX6 is enriched in post-synaptic dendrites [5] , and its overexpression in sensory neurons reduces higher-order dendrite arborization [3] , although it remains unknown whether particular mRNA targets are involved.
C. elegans expresses many conserved mRNA decay factors, whose functions have been mostly characterized in the germline and in early embryos [7] [8] [9] [10] . For example, the CAR-1 protein family includes yeast Scd6, Drosophila Tral (Trailer hitch), Xenopus RAP55, and mammalian LSM14 [11] . The interaction between CAR-1/LSM14 and CGH-1/DDX6 regulates the formation of endoplasmic reticulum and anaphase spindle network; loss of function in car-1 or cgh-1 leads to sterility and embryonic lethality due to defects in germline apoptosis and embryonic cytokinesis [7, 8, 10] . Loss of function in cgh-1 has recently been shown to affect dendrite development in PVD neurons [6] . However, the neuronal mRNA targets of CAR-1 or CGH- 1 have not yet been identified.
Here, we show that loss of the translational repressors CAR-1 or CGH-1 results in axon breakage and branching, and increased axon regrowth after injury, whereas loss of mRNA decapping factors results in aberrant axon development and decreased axon regrowth after injury. We further identified numerous genes including the mitochondrial calcium ([Ca 2+ ] mt ) regulator micu-1, whose mRNAs are bound by CAR-1 in neurons. We present multiple lines of evidence that CAR-1 represses the expression and translation of micu-1 in neurons. Additionally, we describe a [Ca 2+ ] mt influx induced by axon injury and show that the dynamics of this [Ca 2+ ] mt is regulated by CAR-1 and MICU-1 with dose dependency. Our studies reveal a novel mechanism whereby mRNA decay pathways regulate axonal mitochondrial calcium [Ca 2+ ] mt dynamics.
RESULTS

C. elegans mRNA Decay Factors Are Expressed in Neurons and Localize to Distinct Subcellular Granules
We first asked whether key mRNA decay components were expressed in C. elegans neurons. We performed smFISH (singlemolecule fluorescence in situ hybridization) for endogenous car-1 mRNAs and observed widespread expression in somatic cells including touch receptor neurons (TRNs) and other neurons besides the germline (Figures 1A and S1). We examined functional transgenes of full-length DCAP-1 or CGH-1 expressed under their respective promoters [12, 13] and observed expression in many neurons including TRNs and motor neurons, localizing to cytoplasmic puncta in neuronal cell bodies ( Figures 1B and S2A ). To determine protein localization in single neurons, we generated transgenes expressing various mRNA decay factors using the TRN-specific mec-4 promoter. We found that in TRN cell bodies, CGH-1::GFP fully co-localized with mKate2::CAR-1 puncta (Figure 1C ), whereas DCAP-1::dsRed partially co-localized with GFP::CAR-1 ( Figure 1D ). These results suggest mRNA decay components form at least two types of cytoplasmic granules in C. elegans neurons. The partial colocalization of CAR-1 and DCAP-1 further implies that only some CAR-1-bound mRNAs undergo mRNA decapping and decay ( Figure 1E ).
Assembly of mRNA decay complexes in other organisms involves direct interactions such as binding of DDX6 to LSM14 and of DCP1 to the decapping activator PATL [14, 15] . To address whether punctate localization by C. elegans mRNA decay factors depended on similar interactions, we examined genetic null (0) mutants. Loss of function in patr-1/PATL resulted in fewer DCAP-1 puncta in neurons, whereas loss of function in cgh-1 resulted in dimmer CAR-1 puncta ( Figures S2B and S2C ), indicating that PATR-1 and CGH-1 promote recruitment of DCAP-1 and CAR-1, respectively. In contrast, loss of function in decapping enzymes dcap-1 or dcap-2 increased the size of CAR-1 puncta ( Figure S1C ). In dcap-2(0) mutants, these enlarged CAR-1 puncta showed nearly complete colocalization with DCAP-1 ( Figure S1D ), suggesting that the lack of decapping activity may cause accumulation of granules containing CAR-1 and its bound mRNAs. 
mRNA Decay Components Have Differential Roles in Axon Morphology and Regrowth after Injury
To study the roles of mRNA decay components in neuronal development and maintenance, we focused on the posterior TRN, PLM. In wild-type animals, PLM neurons normally extend a long anterior axon and a short posterior dendrite (Figures 2A  and S3A ). In car-1(0) and cgh-1(0) mutant larvae, PLM neurons displayed normal axon morphology ( Figure S3B ), but in day 1 mutant adults, PLM axons displayed ectopic branching, breakage, and blebbing (Figures 2A, 2B S3A, and S3B), suggesting thatcar-1 and cgh-1 are not essential for PLM axon development, but are necessary for maintaining healthy axon morphology in adults. In contrast, dcap-1(0), dcap-2(0), or dcap-1(0) dcap-2(0) mutants at all larval and adult stages displayed low penetrance hook-shaped axon extensions, in addition to ectopic axon branching and blebbing (Figures 2A, 2B , and S3B), suggesting that decapping enzyme activity is important for PLM development.
Adult PLM axons display robust regrowth following femtosecond laser surgery [16] . We next examined how the mRNA decay factors affected axon regrowth. We severed morphologically normal PLM axons in larval (L4) animals lacking specific mRNA decay components and imaged axon regrowth 24 h post-axotomy (hpa). car-1(0) and cgh-1(0) mutants showed increased regrowth after injury, whereas injured PLM axons in single null mutants for dcap-1, dcap-2, or patr-1, and in dcap-1(0) dcap-2(0) double mutants, all showed decreased axon regrowth ( Figure 2C ). This analysis implies that although these mRNA decay factors can form a protein complex and partly colocalize within the same cell, they exert differential functions in axon development, maintenance, and regrowth. Below, we focus on CAR-1, which is not required for PLM development but is a strong inhibitor of PLM axon regrowth.
CAR-1 Is a Cell-Intrinsic Inhibitor of Axon Regrowth
Three independent car-1(0) mutants all exhibited enhanced PLM axon regrowth after injury in the L4 stage, as well as adult-onset axon morphology defects ( Figures 3A-3C and S3C). The enhanced regrowth in car-1(0) mutants was restored to wildtype levels by single-copy transgenes expressing car-1 using endogenous or TRN-specific promoters, but not using a muscle-specific promoter ( Figure 3B ), indicating that CAR-1 regulates axon regrowth cell-autonomously. Axon regrowth involves initial growth cone formation followed by axon extension [17] [18] [19] . We observed a higher rate of growth cone formation in car-1(0) mutants at multiple time points after axonal injury (Figures 3D and 3E), suggesting that CAR-1 inhibits growth cone formation throughout the process of regrowth. Moreover, overexpression of CAR-1 in TRNs resulted in severe axonal defects in adult animals and strongly impaired axon regrowth and growth cone formation after injury ( Figures 3B, 3C , and S3C), indicating that axon maintenance and regrowth are sensitive to CAR-1 levels.
CAR-1 Sm and FDF Domains Are Required for Inhibition of Axon Regrowth
CAR-1 contains three conserved domains ( Figure 4A ): an N-terminal Sm domain, an FDF (phenylalanine-aspartate-phenylalanine) motif, and a C-terminal RGG (arginine-glycine-glycine) motif [7, 8] . The Sm domain in yeast Scd6 is essential for mRNA translational repression and stimulation of mRNA decay [20] , and the FDF motif of C. elegans CAR-1 can interact with human DDX6 [14] . We next asked which domain is relevant for CAR-1 cytoplasmic puncta formation and for its function in axon regrowth.
We expressed truncated GFP::CAR-1 in TRNs as single-copy insertion transgenes to ensure consistency in expression level ( Figure 4A ). We found that the FDF and RGG motifs, but not the Sm domain, contribute to the formation of CAR-1 puncta in A B C PLM cell bodies ( Figure 4A ), consistent with observations in C. elegans embryos [7] . To address the function of CAR-1 mutant proteins, we performed axon injury in car-1(0) animals expressing each transgene. Expression of CAR-1(FL) or CAR-1(Sm+FDF), but not CAR-1(Sm), CAR-1(DSm), CAR-1(RGG), nor CAR-1(DFDF+RGG), in car-1(0) mutants restored axon regrowth and growth cone formation to wild-type levels ( Figures  4B and 4C ). These data indicate that the Sm domain and FDF motif of CAR-1, hence its role in RNA translational repression, are critical for CAR-1 function in neurons.
CAR-1 Regulates Its mRNA Expression in PLM Neurons
To identify neuronal targets of CAR-1, we constructed transgenic strains overexpressing GFP::CAR-1(FL) (juIs526) or GFP::CAR-1(DSm) (juIs549) in all neurons using the panneuronal rgef-1 promoter. In axon injury assay, we found that overexpression of GFP::CAR-1(FL), but not GFP::CAR-1(DSm), inhibited PLM axon regrowth ( Figure 5A ), confirming the importance of the Sm domain in CAR-1 function. We then performed single-end enhanced crosslinking and immunoprecipitation (se-CLIP) to isolate mRNA targets of CAR-1 using these transgenic animals (see STAR Methods for details) [21, 22] . We reasoned that mRNAs repressed by CAR-1 should be more stably bound to non-functional GFP::CAR-1(DSm) than to GFP::CAR-1(FL).
We analyzed seCLIP data to identify peaks specifically enriched in GFP::CAR-1(DSm) samples (STAR Methods) and selected about 30 or so potential targets (Table S1 ). Among them, we found that car-1 itself was specifically enriched in GFP::CAR-1(DSm) co-immunoprecipitates ( Figure 5B ), suggesting CAR-1 might repress its own expression. To test this, we performed smFISH for car-1 in animals expressing Pmec-4::GFP::CAR-1 and found that car-1 mRNA puncta partly colocalized with GFP::CAR-1 cytoplasmic puncta in wild-type and dcap-2(0) animals ( Figure 5C ). Since cgh-1(0) mutants display dimmer GFP::CAR-1 puncta ( Figure S1C ), we visualized car-1 mRNAs in cgh-1(0) mutants and observed that cgh-1(0) mutants displayed more car-1 mRNA puncta ( Figures 5D and 5E ), suggesting that car-1 mRNA levels are normally limited by CAR-1/CGH-1 activity.
CAR-1 Binds micu-1 Transcripts and Represses MICU-1::GFP Protein Levels in PLM Neurons
We identified 29 genes whose mRNAs showed enriched peaks in GFP::CAR-1(DSm) seCLIP analysis, including several calciumrelated genes: clp-1, kcnl-1, micu-1, and unc-13 (Table S1) . Several genes were previously analyzed for their roles in PLM axon regrowth [18, 23] . Given recent evidence for the function of mitochondria in axon regrowth [24-26], here we chose to focus on micu-1, which encodes a mitochondrial calcium uptake regulator of the MICU1 family ( Figure S4A ). Careful inspection of the seCLIP peak profiles revealed that GFP::CAR-1(DSm) samples were specifically enriched on micu-1 ( Figure 5B ). To further verify this finding, we performed smFISH of micu-1 mRNA. In wild type PLM neurons, micu-1 mRNA puncta partly colocalized with GFP::CAR-1 ( Figure 6A ), similar to car-1 mRNA. In car-1(0) mutants, we observed increased numbers of micu-1 mRNA puncta in PLM cell bodies ( Figures 6B and 6C ). The increased micu-1 mRNA puncta observed in car-1(0) mutant TRNs was suppressed by expressing CAR-1(FL) or CAR-1(Sm+FDF), but not CAR-1(DSm) ( Figure 6C ), suggesting that CAR-1(Sm) domain mediates translational repression. micu-1 mRNA puncta did not colocalize with GFP::DCAP-1 ( Figure S5A ), suggesting that DCAP-1 does not regulate expression of micu-1 mRNA directly. Next, we characterized endogenous MICU-1 expression by inserting GFP into the carboxy-terminus of the endogenous micu-1 gene (see STAR Methods). MICU-1::GFP was detected at low levels in germ cells, epidermis, and some muscles (Figure S4B ). MICU-1::GFP was detected at low levels in PLM neuron soma, colocalizing with a mitochondrial marker, but was below the limit of detection in axons ( Figure 6D ). As micu-1 transcript levels were increased in car-1(0) mutants, we examined whether MICU-1::GFP signals were different in car-1(0) mutant compared to wild type. We observed a consistent 1.2-fold increase of MICU-1::GFP intensity in PLM cell bodies in car-1(0) mutant compared to wild type ( Figures 6E and 6F) . Collectively, these observations indicate that CAR-1 binds micu-1 mRNA and represses its translation in PLM neurons.
CAR-1-Mediated Inhibition of Axon Regrowth Is
Dependent on the Mitochondrial Calcium Import Factors MCU-1 and MICU-1 MICU1 is an EF-hand protein that forms a complex with the MCU1 uniporter to regulate [Ca 2+ ] mt uptake [27-31]. We therefore hypothesize that axonal mitochondrial calcium uptake might influence regrowth dynamics. To test this, we first asked whether micu-1, or the uniporter mcu-1, affected PLM axon regrowth. We analyzed axon regrowth in double mutants between car-1(0) and mcu-1(0) or micu-1(0). Loss of mcu-1 or micu-1 fully suppressed increased axon regrowth observed in car-1(0) mutants (Figure 7A ). However, loss of mcu-1 or micu-1 did not suppress the increased growth cone formation observed in car-1(0) mutants, indicating that CAR-1 acts via other targets to regulate axon extension and growth cone formation. micu-1(0) also suppressed the adult-onset axon maintenance defects of car-1(0) mutants ( Figure S5B ), suggesting that MICU-1 is acting downstream of CAR-1 in axon maintenance. Loss of mcu-1 or micu-1 did not rescue axon regrowth and axon morphology defects of dcap-1(0) mutants ( Figures S5C and S5D) , implying that micu-1 is a specific target of CAR-1 but not of DCAP-1.
Axon Injury Triggers Mitochondrial Calcium Uptake Dependent on MCU-1 and Regulated by MICU-1
We next addressed whether axon injury might affect [Ca 2+ ] mt flux. We targeted the Ca 2+ sensor GCaMP5 to the mitochondrial matrix (mtGCaMP) in TRNs. micu-1(0), mcu-1(0), and car-1(0) mutants displayed normal axonal mitochondrial distribution and baseline mtGCaMP levels ( Figures S6A and S6B ). We confirmed that injury causes a cytosolic Ca 2+ ([Ca 2+ ] c ) transient ( Figure 7B ) [32] , with no significant difference between wild-type, car-1(0), mcu-1(0), and micu-1(0) mutants (data not shown).
In wild-type PLM axons, injury triggered a rapid increase in mtGCaMP fluorescence, consistent with axonal [Ca 2+ ] mt uptake (Figures 7B and 7C ). We measured the relative change in mtGCaMP fluorescence (DF/F0) and found that the increased mtGCaMP fluorescence peaked within seconds of injury followed by decay to baseline levels after 5 min ( Figures 7B-7D ). Loss of function in mcu-1 abolished the axotomy-triggered mtGCaMP transient ( Figure 7B ). In contrast, micu-1(0) PLM axons showed a higher peak mtGCaMP fluorescence immediately after injury but decayed faster, and by 5 min after injury, had mtGCaMP levels similar to wild-type animals ( Figure 7B ). The increase in mtGCaMP fluorescence observed in wild-type and micu-1(0) axons after injury was dependent on MCU-1, because mcu-1(0) micu-1(0) double mutants did not display any transient mtGCaMP increase following axonal injury, resembling mcu-1 single mutants ( Figure 7B ). Our results show that MCU-1 is essential for the transient [Ca 2+ ] mt uptake after axon injury, whereas MICU-1 appears to inhibit initial Ca 2+ overload, consistent with the gatekeeping function of mammalian MICUs [30, 33, 34] .
car-1(0) Mutants Display More Sustained Axonal [Ca 2+ ] mt Uptake
We further addressed whether the axotomy-triggered [Ca 2+ ] mt influx was regulated by CAR-1 by examining [Ca 2+ ] mt uptake in car-1(0) animals. The mtGCaMP transients triggered immediately (2.4 s after axotomy) by injury in car-1(0) were similar to those in wild-type axons (Figures 7B and 7C ). However, car-1(0) mutants displayed a more sustained elevation in [Ca 2+ ] mt levels compared to wild type; this elevation was completely dependent on MCU-1 (Figures 7B-7D ). As expression of MICU-1 was elevated in car-1(0) mutants ( Figure 6 ), we next tested whether loss of micu-1 was able to restore wild-type [Ca 2+ ] mt levels in car-1(0) mutants. We observed wild-type [Ca 2+ ] mt levels in car-1(0) and micu-1(0) double mutants (Figure 7B) . Further, slight elevation of micu-1 levels in the TRNs resulted in increased axon regrowth and sustained axonal [Ca 2+ ] mt uptake after injury ( Figures S7A-S7C ). Axon regrowth was impaired when micu-1 was overexpressed to a high level ( Figure S7A ), suggesting axon regrowth is sensitive to the level of MICU-1. Overall, our results suggest that mild elevation of MICU-1 expression is responsible for the more sustained [Ca 2+ ] mt uptake and increased axon regrowth of car-1(0) mutants upon axon injury.
DISCUSSION
In this study, we find that CAR-1 and other mRNA decay factors play multiple roles in C. elegans axon development, axon maintenance, and axon regrowth. We further dissected the mechanism by which CAR-1 inhibits axon regrowth after injury. We presented multiple lines of evidence that the mitochondrial calcium regulator MICU-1 is a major CAR-1 target in axon regrowth. We also show that the regulation of MICU-1 by CAR-1 is important for fine-tuning injury-induced [Ca 2+ ] mt transients. Our data reveal a previously unknown molecular pathway linking mRNA decay and axonal [Ca 2+ ] mt dynamics.
Our analyses on C. elegans mRNA decay factors are consistent with an emerging notion that these factors have distinct in vivo functions. Focusing on the PLM neurons, we show that mRNA decay factors localize to at least two main subcellular granules, as the decapping enzymes are present in a subset of granules containing translational repressors. These observations are consistent with reports that in Drosophila neurons, decapping enzymes partly colocalize with the translational repressor Me31B/DDX6 [5] . Our data further show that mRNA decapping factors DCAP-1 and DCAP-2 are required for PLM developmental axon guidance and regrowth, whereas translational repressors CAR-1 and CGH-1 are not essential for PLM axon development but inhibit PLM axon regrowth and maintain adult axon integrity. We have found that MICU-1, a member of a highly conserved family of [Ca 2+ ] mt regulators, is a major functionally relevant target of neuronal CAR-1. micu-1 transcripts are present in CAR-1-positive, DCAP-1-negative granules, suggesting different mRNA decay factors regulate expression of distinct mRNA targets. Our observation that in the absence of DCAP-1 or DCAP-2, the mRNA targets of CAR-1 accumulate in larger CAR-1 granules, suggests that increased binding of CAR-1 to its mRNA targets likely leads to translational repression, potentially accounting for the axonal developmental defects and decreased axon regrowth in decapping enzyme mutants.
We find that at least two domains of LSM14 family proteins are important for translational repression. The Sm domain is essential for binding to 4E-T, and the FDF domain binds to DDX6/CGH-1 and serves as a platform for other mRNA decay factors [14, 35] . We find that truncated CAR-1(Sm+FDF) protein can suppress the increased micu-1 transcript level of car-1(0) mutants, despite not forming distinct puncta in neurons. Our findings are consistent with prior studies showing the RGG motif is dispensable for translational repression [36, 37] . Moreover, translational repression has been observed in the absence of visible cytoplasmic puncta formation [38, 39] . Taken together, our results suggest that CAR-1 may bind to and repress translation of mRNA targets even in the absence of visible puncta.
Through characterizing in vivo mRNA targets of CAR-1 in neurons, we have uncovered a previously unknown pathway involving mitochondria calcium regulation in axon injury. The functions of mitochondrial calcium uniporter MCU complex critically depend on its regulatory subunits, including the MICU proteins and cytoplasmic calcium (reviewed in [40, 41] ), and are important for human health. Mutations in human MICU genes have been linked to neurological disorders [42] [43] [44] , and MCU itself is implicated in excitotoxic neuronal cell death [45] . [Ca 2+ ] mt dynamics affect multiple aspects of cellular metabolism, including oxidative phosphorylation, Ca 2+ buffering, and reactive oxygen species production, so abnormal [Ca 2+ ] mt dynamics could affect neuronal development and function in several ways [46] . Emerging evidence links elevated [Ca 2+ ] mt uptake to axonal degeneration in vertebrates [47, 48] and in C. elegans [49] . Moreover, increased Ca 2+ levels in traumatic brain injury can be ameliorated by the inhibition of MCU1 [50] , suggesting potential therapeutic benefits of mitochondrial Ca 2+ regulation in brain injury. Loss of function in Drosophila MCU or MICU causes aberrant axon morphology and impairs memory formation [51] . Interestingly, expression levels of MCU and MICU are dependent on neuronal cell type and Ca 2+ signaling [52] . Our results reveal that neuronal MICU-1 levels are fine-tuned by the mRNA decay machinery, adding another level of regulation to neuronal [Ca 2+ ] mt dynamics.
Axon injury triggers a transient elevation in [Ca 2+ ] c [17, 32, 53] . In C. elegans neurons, increased [Ca 2+ ] c could contribute to the activation of the conserved kinase DLK-1, thereby promoting axon regrowth [54, 55] . Here, we reveal that axon injury also triggers axonal [Ca 2+ ] mt uptake in C. elegans, reminiscent of observations in vertebrate neurons [56] . We find that this [Ca 2+ ] mt uptake is completely dependent on MCU-1 and is regulated in complex ways by MICU-1. In cultured mammalian cells, MICU1 localizes to mitochondria [31, [57] [58] [59] and inhibits MCU function at low [Ca 2+ ] c levels (known as ''gatekeeping''), but at higher [Ca 2+ ] c levels, Ca 2+ binds to MICU1 to stimulate MCU1 opening [33, 34, 59] . MICU1 therefore can inhibit or promote MCU function depending on the [Ca 2+ ] c level. Supporting this model, our data show that loss of function in micu-1 and mcu-1 have opposing effects on the amplitude of the initial [Ca 2+ ] mt transient after axotomy. However, the enhanced axon regrowth of car-1(0) mutants is suppressed to a similar degree by loss of function in mcu-1 or micu-1. Our data suggest that the MCU-1-stimulating role of MICU-1 at lower [Ca 2+ ] c is most relevant to the long-term outcome in axon regrowth.
MCU function is sensitive to the stoichiometry of MICU and other regulatory subunits. For example, liver mitochondria have a higher MICU1:MCU1 ratio than heart or muscle mitochondria and display increased cooperativity of [Ca 2+ ] mt uptake [60] . We propose that in PLM neurons, CAR-1 tightly regulates MICU-1 expression via mRNA decay machinery. car-1(0) mutants have a higher MICU-1:MCU-1 ratio, causing increased [Ca 2+ ] mt uptake after axon injury and enhanced axon regrowth ( Figure 7E ). Axonal transport of mitochondria has been shown to boost regrowth in C. elegans and mammalian neurons [24] [25] [26] . Our observations suggest that more sustained [Ca 2+ ] mt uptake also promotes axon regrowth, for example potentially through increasing ATP production required for axon repair [61] . We speculate that the mild enhancement of [Ca 2+ ] mt uptake resulting from elevated MICU expression is insufficient to trigger deleterious consequences such as opening of the mitochondrial permeability transition pore that would lead to axonal degeneration. Precise modulation of [Ca 2+ ] mt uptake in injured neurons may provide new therapeutic routes toward effective axon repair.
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Detailed methods are provided in the online version of this paper and include the following: 
